Back

Viatris announces Japan approval of WAKIX for narcolepsy and sleep-apnea-related sleepiness

Verifying
  • Viatris announced Japan’s approval of WAKIX for narcolepsy and sleep-apnea-related sleepiness.
  • WAKIX contains pitolisant and is described as a first-in-class treatment.
  • The approval covers excessive daytime sleepiness associated with obstructive sleep apnea syndrome.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.